Cocrystal Pharma Investor Presentation May 2020

Cocrystal Pharma presented its pipeline progress and strategic partnerships, including a collaboration with Merck on influenza programs. The company outlined development timelines for COVID-19 therapeutics, HCV, influenza, and norovirus programs, with expected milestones through Q4 2020.